Federal officials say regulators should reach a decision about whether to approve Canada’s first COVID-19 vaccine for infants and preschoolers in coming weeks as the U.S. prepares to roll out tot-sized shots.
Deputy Chief Public Health Officer Howard Njoo told a news conference this morning that Health Canada continues to review Moderna’s application for a vaccine to protect children between six months and five years old.
